Crossmark

Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma

Crossref DOI link: https://doi.org/10.1007/s00277-018-3279-8

Published Online: 2018-02-17

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nakazato, Tomonori

Takanashi, Satoshi

Hirano, Motoharu

Ito, Chisako

Fujita, Yuriko

Osada, Yuki

Aisa, Yoshinobu

Mori, Takehiko
License Information

Text and Data Mining valid from 2018-02-17
More Information

Article History

Received: 22 January 2018

Accepted: 10 February 2018

First Online: 17 February 2018

Compliance with ethical standards

: Written informed consent was obtained from the patient for publication.

: The authors declare that they have no conflict of interest.